Update on the NIH Chelation Trial

The federal Trial to Assess Chelation (TACT) study is once again enrolling heart attack survivors. The study’s leader, Dr. Gervasio Lamas of the Mt. Sinai Medical Center in Miami, voluntarily suspended enrollment last fall after allegations were published in Medscape critical of the consent form given to patients and of the safety of the trial.The […]

Read More

Big Pharma and the FDA: Suppress the Science, Ban the Natural Substances, Sell the Drugs!

In 2005, an up-and-coming pharmaceutical company made a big mistake: they invested millions of dollars into developing a drug only to discover that the only active ingredient of the drug, pyridoxamine, was really a common, naturally occurring substance that has been sold for decades at low cost to consumers in the form of a dietary […]

Read More

FDA to Receive More Money from Drug Manufacturers, But Denies “Undue Influence”

The proposed budget of the US Food and Drug Administration (FDA) is worrying the Democrats. They are concerned that FDA’s annual increases in industry user fees—$828 million from manufacturers of medical and food products, including hundreds of millions drug manufacturers pay annually to help speed the review of new medicines—might compromise the agency’s independence.

Read More

Nineteen Members of Congress Ask FDA for Official Warning About Mercury in Dental Filling Amalgams

A bipartisan letter authored by Rep. Diane Watson (D-CA) and Rep. Dan Burton (R-IN), and co-signed by congresswomen and men from twelve states, has been sent to the FDA urging them to require clear warnings about mercury toxicity to every dental patient, and to establish specific protections for children and young women.

Read More

Vermont Acts to Make Drug Makers’ Gifts Public

Under a new Vermont law, drug and device manufacturers will have to publicly disclose all gifts (in direct payments, speaking and consulting fees, grants, food, lodging and transportation, and books) they make to healthcare providers. The law will require specific disclosure of doctors’ names, dollar amounts, and the medical products to which the spending is […]

Read More